“Sanofi is a global leader in immunological and inflammatory ... Alzheimer’s disease, and multiplesclerosis, among others. In the first quarter of this year, Ventyx announced results from a ...
Data also showed that the number of participants who experienced confirmed disability improvement increased by around two-fold. Liver enzyme elevations were observed in 4.1% of participants ...